Loncar Lyon Jenkins is now filing Benicar side effects lawsuits in order to ensure victims of Benicar gastrointestinal damage receive due compensation
Benicar, also know as Olmesartan Medoxomil in generic form, is a prescription medication manufactured by Daiichi Sankyo for the treatment of high blood pressure. Since its approval by the U.S. Food & Drug Administration in 2002, more than 10 million patients have been prescribed Benicar. The drug has shown success in reducing blood pressure and is the most widely prescribed blood pressure medication in the United States.
CLINICAL STUDIES OF BENICAR EXPOSING GASTROINTESTINAL DAMAGE
Benicar comes with a handful of commonly recognized side-effects but has just recently been linked to severe gastrointestinal side effects. In 2012 the Mayo Clinic reported, “Olmesartan may be associated with a severe form of spruelike enteropathy. Clinical response and histologic recovery are expected after suspension of the drug”. Spruelike enteropathy is a gastrointestinal disorder with symptoms that include severe, chronic diarrhea and substantial weight-loss. Chronic diarrhea can lead to severe dehydration resulting in hospitalization and sometimes death. The Mayo Clinic study was enough for the FDA on July 2013 to mandate label changes for Benicar to include intestinal problems. Further studies have since come out verifying the link between Benicar and gatrointestinal damage. In May 2014 the medical journal Gastroenterology published an article concluding that, “[Benicar (olmesartan)] was associated with an increased risk of severe intestinal malabsorption. The increased risk appears after one year of treatment and reaches 9.53 after 2 years of [Benicar (olmesartan)]. ARBs other than [Benicar (olmesartan)] were not associated with an increased risk of severe intestinal malabsorption”. This study notes that while Benicar exhibits an increased risk for gastrointestinal damage, similar ARB drugs do not. It has also been shown that discontinuing usage of Benicar will reverse symptoms of spruelike enteropathys in all patients, furthering the direct link between Benicar and gastrointestinal damage. If you are currently prescribed Benicar, make sure to consult your physician before discontinuing use. Do not discontinue use without physician approval.
BENICAR SIDE EFFECTS LAWSUITS
Patients who suffered from chronic diarrhea, severe weight loss, nausea, and vomiting after taking Benicar have begun suing the manufacturers Daiichi Sankyo and Forest Laboratories. These lawsuits seek to compensate victims for expensive medical bills, lost income from time off work, and emotional distress. These lawsuits claim that that Daiichi Sankyo and Forest Laboratories knew or should have known about the risk of intestinal problems before marketing their product. Benicar was approved in 2002 but the label change was not implemented until 2013. The manufacturers failure to properly warn users and prescribers of the links between Benicar use and severe GI problems, unnecessarily injuring thousands of Americans. If you or someone you love were among those needlessly injured as a result of taking Benicar, you may be eligible for compensation. Contact Loncar Lyon Jenkins immediately for a free, confidential case evaluation using the form on the side or by calling toll free at 800.285.4878. Benicar side effects lawsuits are being evaluated on a contingency fee basis, meaning you pay nothing unless a recovery is obtained.